After reformulating with HFA propellant and changing the inhaler device, Primatene Mist became available OTC again in 2018.

However, also like Primatene, Asthmanefrin was significantly less effective at controlling asthma symptoms than prescription albuterol. Primatene Mist inhalers provide temporary relief from mild, ...

Leak Rate. It is common for MDIs to lose propellant during storage. The propellant-leak rate of the test MDIs was compared with that of the controls (Figure 3). The leak rates for the Proventil ...

In children with significant respiratory distress, we initiate a dose of either 75 mg/hr (half diluted 5 mg/mL) albuterol solution delivered via a HEART nebulizer (High-output Extended Aerosol ...

Busting the myth: Albuterol nebs are more effective than albuterol inhaler. What are the advantages and disadvantages of MDIs and nebulizers? • A Cochrane review demonstrated that an MDI with a ...

Childhood asthma leads to over 10 million missed school days annually in the U.S., making it a significant contributor to chronic illness-related school absenteeism. In the U.S., nearly 25 million ...

Nine-year-old Bryce Shaw loves being outside with his mom in South Jersey throwing around a baseball but lately, it's been ...

The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more ...

Asthma inhalers are hand-held devices that allow you to inhale a dose of medication to treat asthma symptoms. There are many types of asthma inhalers. They differ in whether they're used for quick ...

A first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide (an anti-inflammatory ...

Q3 2024 Earnings Call Transcript November 6, 2024Amphastar Pharmaceuticals, Inc. misses on earnings expectations.